STAT Plus: The coronavirus pandemic could shrink some biotech startup valuations
Determining a private company’s value means estimating how and when it might be able to…
Category: STATPlus
STAT Plus: Pharma execs criticize a drug maker over pricing and claim orphan drug law is being misused
Several prominent biotech and pharmaceutical executives are openly criticizing a huge price hike for a…